Kyle Berg received an undergraduate degree in biology and biochemistry from Utah State University and remained there to complete his master’s degree studying the molecular biology of the aggregate web-glue protein of the orb-weaving spider Trichonephila clavipes. He obtained a doctorate in chemistry and biochemistry from the University of California, San Diego, where he studied the actin-bundling protein fascin-1, its role in neurodegeneration and small molecules that alter its activity. At Quansys Biosciences, Dr. Berg has fulfilled roles as scientist, senior scientist and manager of research and development, overseeing the development of multiplexed ELISA immunoassays and investigating the use of non-antibody binding molecules in ELISA applications. He enjoys the opportunities his position gives him to analyze data, design experiments and teach the application of scientific principles to his team.